Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03163511

A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

Type 1 Diabetes Mellitus With Hypoglycemia Clinical Trial

Official title:
An Open-Label, First-In-Human Study Evaluating the Safety, Tolerability, and Efficacy of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

Clinical Trial Summary

VC02-101 will evaluate an experimental cell replacement therapy intended to provide a functional cure to subjects with Type 1 Diabetes and Hypoglycemia Unawareness.

Clinical Trial Description

The purpose of this trial is to test if VC-02™ combination product can be implanted subcutaneously in subjects with Type 1 Diabetes and Hypoglycemia Unawareness and maintained safely for up to two years. It will also test if VC-02 is an effective treatment for these subjects. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03163511
Study type Interventional
Source ViaCyte
Contact
Status Completed
Phase Phase 1/Phase 2
Start date July 6, 2017
Completion date October 19, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT04712266 - A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes Early Phase 1
Recruiting NCT05967260 - DailyDose Smart Snack Study for T1D on MDI N/A
Completed NCT06097689 - A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus N/A
Completed NCT03286816 - The Effect of Intravenous Lactate on Brain Lactate Concentrations During Hypoglycemia N/A
Recruiting NCT05221359 - Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes N/A
Recruiting NCT06382350 - Glycemic Excursions in Patients With Type 1 Diabetes Mellitus Using Closed-loop Systems
Recruiting NCT04266379 - Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia N/A
Recruiting NCT05762107 - A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes Phase 2
Active, not recruiting NCT04614168 - Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes N/A
Completed NCT03028220 - Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous Glucose Data N/A
Enrolling by invitation NCT04233138 - SUPPORT Online Training Platform for Type 1 Diabetes Self-management Education and Support (SUPPORT) N/A
Recruiting NCT04664764 - Intermediate and Long Acting Insulin Young Children Type 1 Diabetes. Phase 4